decade. In Taiwan, the NHI had reported 6519 primary THA procedures in 2004, with an increased rate of 2.1 percent. 4 The numbers of primary THA procedures increased substantially from 1990 to 2002 in the US, 5 with their volume predicted to double by the year 2026. 6 Since the supply of modern surgical techniques has improved and the aged population has increased, THA procedures were expected to be augmented. With an increased demand, the issue of preserving limited healthcare resources for specific groups of patients would be a mutual interest among clinicians, hospital administrators and policy makers. 7 The volume-outcome studies on total joint arthroplasty reported that increased rates of dislocation, infection, and death were associated with lower provider volume after total joint arthroplasty. 8, 9 Higher rates of complications were found at low-volume providers after total knee and shoulder arthroplasty. 7,10−13 In addition, the relationship between provider volume and economical outcome has also been confirmed. 14−16 Acute infection and perioperative complication are major concerns with THA because of the great consumption of hospital utilization and high morbidity and mortality. 8, 9 However, there is limited information about the impact of perioperative adverse events on hospital costs and hospital days for patients who underwent elective primary THA. The purposes of this study were to examine the impact of surgeon or hospital volume on hospital utilization; to explore the association of perioperative complication and acute infection with the magnitude of hospital utilization among patients who underwent primary THA, controlled for demographic characteristics; and to identify the major determinants that might explain the differences in hospital utilization. Figure) , i.e. primary or secondary diagnosis of osteomyelitis, or another type of bone infection, fracture, tumor, or codes suggestive of complications of a previous arthroplasty (n = 495); bilateral total hip arthroplasty (n = 236); THA with minor surgeries or procedures (n = 47); treatment costs lower than NHI payment standard (n = 123). Therefore, 9335 (91.2%) cases were included in the study population.
Materials and Methods

Sample selection and exclusion criteria
Outcome measures
The following outcomes reported in the NHIRD were evaluated for the whole study population: in-hospital adverse events, total hospital discharge, and length of stay. For this study, in-hospital adverse events were defined as acute infection and perioperative complications. Mortality was excluded as an outcome variable, because of a minimal incidence rate (0.02%). Acute infection was defined as both cellulitis (ICD-9CM code: 682.2) and wound infection (ICD-9CM code: 998.5) in some studies. 7, 10 The indicators of perioperative complications can be categorized as pulmonary embolism, 8, 12 deep venous thrombosis, 7,9 acute myocardial infarction, 12 pneumonia, 12 urinary tract infection 9 and upper gastrointestinal bleeding. Among the study population, however, the above-mentioned complication cases were too few to support multivariable logistic analysis. Therefore, we aggregated the above adverse events as perioperative complications and acute infection, which were coded dichotomously. ). The CCI has been validated as a proxy of illness severity in previous THA outcome studies. 9, 10, 13 Hospital-specific covariates were ownership (public vs. private, and profit vs. nonprofit) and hospital accreditation status (medical center, regional hospital, and district hospital).
Provider volume measures
Statistical analyses
Descriptive statistics included means or percentages and 95% confidence intervals. Analysis of variance was adopted to examine the three volume groups for statistical differences in continuous variables (length of stay, total hospital charge). Bivariate analyses were performed to measure the association between surgeon and hospital caseload and the remaining covariates. Multivariate regression models were used to examine (after adjusting) age, gender, comorbidity, types of arthritis diagnosis, as well as hospital attributes. Length of stay and total hospital charge in the hospital were treated as a continuous variable. The presence or absence of an adverse event was treated as a binary variable. Ordinary linear or logistic regression requires that all observations should be statistically independent of one another. This assumption was violated in our data because multiple patients received care by the same surgeons/hospitals. Generalized estimating equations (Proc Genmod; SAS Institute, Gary, North Carolina, USA) were therefore used to cluster patients within hospitals. Interaction between covariate, surgeon volume and hospital volume were individually tested for every model. The interaction term between hospital and surgeon volume was also evaluated by entering it into the model after all main effects had been included. None of the interactions were found to reach significance. The outcome rate of acute infection was not sufficient to perform a regression analysis, because of the relatively low rates in our datasets.
Results
Patient population and provider volume
In total, 715 orthopedic surgeons in 232 hospitals performed THA for 9335 subjects, of which, low-, medium-, and high-hospital volume groups accounted for 272 (2.9%), 1914 (20.5%), and 7149 (76.4%), respectively. Low-, medium-, and high-surgeon volume groups accounted for 451 (4.83%), 478 (26.55%), and 6406 (68.62%), respectively. Patient volume distribution was skewed in both surgeons and hospitals. Approximately 76.6% and 68.26% of THA procedures were performed in 20% of the hospitals and by 20% (20) of the surgeons. Stratification of surgeon volume revealed mean annual volumes of 1.03 (range 0.5-1.5), 4.8 (range 2-7.5) and 40.29 (range 8-119) in the low-, medium-and highvolume surgeons, respectively (Table 2) . Stratification of hospital volume revealed mean annual volumes of 4.33 (range 0.5-4), 25.43 (range 9-46) and 351.39 (range 23.5-577) in the low-, medium-and high-volume hospitals, respectively (Tables 1 and 2) . Table 1 indicates that the subjects treated by hospitals from the high-volume group were younger than those in medium-and low-volume groups (p < 0.001). Compared with low-volume surgeons and hospitals, medium-and high-volume surgeons and hospitals treated a higher percentage of female patients (p < 0.001). The patients treated by/at lower surgeon/hospital volumes had higher CCI (p < 0.05). Provider volume groups differed significantly in terms of average length of stay and total hospital charge (p < 0.001). Low-volume surgeons tended to have longer length of stay and higher hospital charge than those of high-volume groups. Patients treated at medium-volume hospitals had longer length of stay and more hospital charge than those of low-volume and high-volume hospitals.
Models of medical utilization
A multivariate regression model was used to predict the length of stay and total hospital charge. We found that surgeon volume, CCI score, acute infection, and perioperative complication were significantly related with both length of stay and total hospital charge. In addition, linear but reverse associations among surgeon volume, length of stay and total hospital charge were delineated. The lengths of stay for subjects treated by high-/ medium-volume surgeons were −1.31 (p < 0.001) and −0.66 days (p = 0.015) shorter than those of their counterparts treated by low-volume surgeons, after adjusting for case mix (Table 3) . Similarly, total hospital charge for subjects treated by/at high-/medium-volume surgeons was NT$7056 (p < 0.000) and NT$4827 (p = 0.003) lower than those of their counterparts treated by low-volume surgeons. Total hospital charge for subjects treated at high-/medium-volume hospitals was NT$199 (p = 0.894) and NT$1581 (p = 0.246) more than those of their counterparts treated at low-volume hospitals and the lengths of stay for subjects treated were −0.32 (p = 0.344) and 0.35 days (p = 0.286) less than those of their counterparts treated at low-volume hospitals, but these differences did not reach significance.
Increased severity of comorbidities and age among the subjects were positively associated with the length of stay and total hospital charge (Table 3) . Subjects with CCI ≥ 2 tended to have 1.61 days longer hospital stay and NT$14,365 higher hospital charge than those of CCI = 0.
The increment of age also had a significant effect on total hospital charge (NT$75/year) and length of stay (0.02 days/year). However, no significant association between gender and hospital utilization was found. In addition, no significant effects of osteoarthritis, rheumatoid arthritis and avascular necrosis on length of stay and total hospital charge were found; nevertheless, diagnosis of other joint disease tended to have a significant effect on length of stay and total hospital charge.
Subjects with acute infection and perioperative complication also had significant effects on length 
Adverse-outcomes models
A total of 35 (0.37%) subjects had acute infection during their hospitalization, while 141 (1.51%) subjects had perioperative complications. Multivariate analyses demonstrated that subjects' age and CCI were significant predictors of perioperative complication. However, no significant predictors were found in terms of provider volume indicators. The likelihood of perioperative complications among subjects with CCI score ≥ 2 and equal to 1 were 8.22 (p < 0.000) and 2.09 (p = 0.000) times greater than those of subjects with CCI score = 0, respectively (Table 4) .
Discussion
Effect of provider volume on economical outcomes
Subjects treated by higher volume surgeons tended to have less total hospital charge and shorter length of stay than their counterparts after adjusting for patients' age, gender, comorbidity, type of arthritis diagnosed, as well as hospital attributes. Our findings are consistent with those of previous volume-outcome studies that demonstrated a reverse relationship between surgeon provider volume and hospital utilization. 7,9,13 Although total hospital charge was greater in higher volume hospitals and length of stay was longer in medium-volume hospitals compared with lowvolume and high-volume hospitals, these trends did not reach significance. Individual surgeon experience rather than hospital factors were, therefore, significantly associated with hospital utilization. This finding suggests that the hospital services, protocols, and standards did not appear to affect the hospital utilization as much as the experience of individual surgeons. In our study, we found that THA procedures in Taiwan were mainly performed by high-volume providers (Tables 1 and 2) , which tended to consume less hospital utilization (i.e. shorter length of stay and lower total hospital charge). Thus, the surgeon volume of THA can serve as a proxy of a cost containment indicator for third-party payers.
Effect of comorbidity on economical and medical outcomes
In our study, comorbidity had a profound effect on both hospital utilization and medical outcomes. Subjects with CCI ≥ 2 tended to cost an extra NT$14,365 and stayed in hospital 1.61 more days than subjects with CCI = 0. This finding is consistent with previous studies. 19 In addition, the risk of perioperative complication for subjects with CCI ≥ 2 were 8.22 and 2.09 times greater than those of subjects with CCI = 0. Previously, patients with a CCI > 2 have been reported to have a 6.5 times greater risk of dying within 90 days after surgery. 20 Kreder found that patients with CCI ≥ 2 were 24 times more likely to die within 3 months after admission, and were twice as likely to suffer in-hospital complications. 9 Thus, we concur that CCI is an effective instrument for surgeons, hospitals and healthcare systems to identify patients and/or groups of patients at high risk of medical resource consumption and adverse outcomes.
Effect of medical outcomes on economical outcomes
In addition to provider volume, this study delineated that acute infection and perioperative complication also had a significant effect on length of stay and total hospital charge. The occurrences of acute infection and perioperative complication increased the length of stay by 8.22 and 2.09 days and total hospital charge by NT$32,451 and NT$14,365, respectively. These findings revealed that the magnitude of effects of acute infection and perioperative complication on length of stay and total hospital charge were even greater than those of provider volume. Though the incidence rates of acute infection and perioperative complication were slim in our study (0.37% and 1.51%), with the latter being five times greater than the former. Nevertheless, the magnitude of effect of acute infection on length of stay was almost four fold that of perioperative complication (8.22 vs. 2.09 days); and the magnitude of effect of acute infection on total hospital charge was double that of perioperative complication (NT$32,451 vs. NT$14,365). A previous study demonstrated that the treatment for infected THA is significantly associated with greater resource utilization, compared with the treatment for revision THA because of aseptic loosening or primary THA. 21 Therefore, avoiding acute infection would be the rule of thumb for reducing hospital utilization and medical resource consumption. This study confirmed the significant relationships between provider volume and economical and medical outcomes, and also found significant associations among hospital utilization, CCI, and provider volume. The occurrence of perioperative complication and acute infection also had significant influence on hospital utilization, particularly acute-operative infection.
The major strength of our study was the large population-based sample; however, there are some limitations in our study. First, the claim data were not originally designed for clinical research and was thus unable to measure functional outcomes, pain relief, and/or patient satisfaction. Second, the present study did not define the minimally acceptable volume thresholds, and the volume cutoff points were based on the quartiles. Lastly, comorbidity and adverse events were derived from secondary diagnostic codes, which may not be recorded correctly, and their incidence may be overestimated. Fortunately, miscoding would happen systematically and the bias would be minimal.
